DOACs Post-Revascularization - Can We Decrease Major Adverse Limb Events (MALE) and Improve Outcomes?Conference Highlights
Dr. Marc Bonaca, Dr. Sean Lyden and Dr. Raghu Kolluri discuss how to properly incorporate direct oral anticoagulants (DOACs) into treatment plans for patients with peripheral artery disease (PAD). They evaluate the latest data on DOAC therapy and provide strategies for treating and protecting against thrombotic events in patients with PAD post-revascularization.
Faculty: Marc Bonaca, MD, MPH; Sean Lyden, MD; Raghu Kolluri, MD
Expiration Date: August 30, 2022
CME/CE is no longer available for this activity